Tarsus Pharmaceuticals, Inc. logo TARS - Tarsus Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 7
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $84.00 DETAILS
HIGH: $100.00
LOW: $68.00
MEDIAN: $84.00
CONSENSUS: $84.00
UPSIDE: 34.92%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2018 Q2 2018 Q1
Revenue
Revenue 162.1 151.7 118.7 102.7 78.3 66.4 48.1 40.8 27.6 13.1 1.9 0 2.5 10 0 15.3 0.5 0.3 1.2 22.0 33.4 0 0 0 0 0 0 0 0
Cost of Revenue 9.4 10.9 24.6 6.2 5.2 4.9 3.2 3.0 1.7 1.2 0.4 0.3 0.3 0.4 0.2 0.5 0.0 (0.0) 0.1 0.7 1.3 0 0 0 0 0 0.0 0 0
Gross Profit 152.7 140.7 94.1 96.4 73.1 61.5 44.9 37.8 26.0 11.9 1.5 (0.3) 2.2 9.6 (0.2) 14.8 0.5 0.4 1.2 21.3 32.1 0 0 0 0 0 (0.0) 0 0
Operating Expenses
R&D Expenses 22.4 18.0 16.3 15.6 14.4 16.9 12.1 12.3 12.1 13.3 12.1 12.5 12.4 10.0 10.9 9.6 12.1 8.0 10.2 7.2 16.3 7.6 8.0 1.7 1.5 0.7 0.4 0.2 0.2
SG&A Expenses 136.4 130.7 108.6 103.0 85.0 69.0 57.9 58.8 51.6 43.0 30.3 20.0 14.8 14.6 11.8 10.4 7.9 6.8 6.7 6.8 5.2 3.9 2.1 1.5 0.6 0.4 0.2 0.1 0.1
Other Expenses 0 0 (16.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.7) (0.7)
Operating Expenses 158.8 148.7 108.6 118.6 99.4 85.9 70.0 71.1 63.6 56.3 42.4 32.5 27.2 24.7 22.7 20.0 20.0 14.8 16.9 14.0 21.4 11.5 10.1 3.3 2.1 1.1 0.6 (0.3) (0.3)
Operating Income
Operating Income (6.1) (8.0) (14.5) (22.2) (26.3) (24.4) (25.2) (33.3) (37.7) (44.5) (40.9) (32.8) (25.0) (15.1) (22.9) (5.2) (19.5) (14.4) (15.7) 7.3 10.7 (11.5) (10.1) (3.3) (2.1) (1.1) (0.6) (0.3) (0.3)
Interest Expense 2.1 2.2 0 2.1 2.1 2.2 2.3 2.1 1.0 1.0 0.9 0.8 0.7 0.7 0.6 0.5 0.3 0 0 0 0 0 0 0 0.0 0.0 0 0
Interest Income 3.7 4.0 1.8 4.2 3.5 3.6 4.1 4.1 3.1 3.0 2.8 2.2 2.3 2.1 1.1 0.3 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0 0 0 0
Profitability
EBITDA (5.7) (3.7) (12.1) (17.6) (22.4) (20.4) (20.7) (30.9) (34.5) (40.6) (38.1) (30.4) (22.7) (12.8) (21.8) (5.1) (19.9) (14.4) (16.0) 6.5 10.8 (11.4) (10.1) (3.2) (2.1) (1.1) (0.6) (0.3) (0.3)
EBIT (6.1) (4.1) (12.6) (18.1) (22.9) (20.8) (21.0) (31.2) (34.7) (40.9) (38.3) (30.6) (22.8) (12.9) (21.9) (5.2) (19.9) (14.4) (16.0) 6.4 10.7 (11.5) (10.1) (3.3) (2.1) (1.1) (0.7) 0 0
Income Before Tax (9.3) (6.3) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.8) (16.0) 6.4 10.7 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
Income Tax Expense (2.4) 2.1 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) 0 0.0 0.1 (0.3) 0.0 0.3 0 0.0 0 0 0 0 0.0 0.0
Net Income (7.0) (8.4) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.9) (15.7) 6.3 10.3 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
Per Share Data
EPS (Basic) -0.16 -0.20 -0.30 -0.48 -0.64 -0.60 -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.88 -0.53 -0.84 -0.24 -0.98 -0.72 -0.76 0.31 0.51 -0.56 -0.54 -0.30 -0.18 -0.13 -0.06 -0.08 -0.08
EPS (Diluted) -0.16 -0.20 -0.30 -0.48 -0.64 -0.60 -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.88 -0.53 -0.84 -0.24 -0.98 -0.72 -0.76 0.29 0.47 -0.54 -0.54 -0.30 -0.18 -0.13 -0.06 -0.08 -0.08
Shares Outstanding 43.0 42.8 42.6 42.4 39.3 38.6 38.4 37.8 35.3 31.9 30.6 26.8 26.7 25.7 26.7 24.3 20.7 20.6 20.6 20.6 20.3 20.3 18.8 10.9 10.9 10.9 10.9 4.3 4.3
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2019 Q4
Current Assets
Cash & Cash Equivalents 102.2 183.6 112.7 96.6 175.8 94.8 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.1 58.0
Short-Term Investments 286.5 233.6 289.1 284.5 232.1 196.6 140.7 142.5 104.8 2.5 20.2 71.5 135.2 145.4 57.1 0 0.3 0.5 0 0 0 0 0 0 0
Net Receivables 117.2 87.1 74.3 60.2 64.2 48.1 30.3 30.8 31.4 17.7 6.4 0.2 2.9 3.6 4.0 0.6 0.3 0.1 0.1 20.2 32.4 0.0 0.0 0.0 0.0
Inventory 4.6 4.4 3.8 3.9 2.7 2.6 2.8 2.2 4.0 3.1 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 2.3 1.1 0.0
Total Current Assets 537.2 522.8 501.7 474.4 480.8 356.7 357.1 362.6 340.7 256.1 259.3 183.5 208.6 225.4 234.1 250.3 178.8 176.0 187.1 200.9 191.5 170.7 89.1 54.7 58.0
Non-Current Assets
Property, Plant & Equipment 27.7 21.7 16.0 3.4 3.2 2.9 4.2 4.2 3.5 3.3 3.6 3.7 1.7 1.5 1.6 1.8 1.8 1.8 1.7 1.0 1.2 1.2 1.4 1.4 0.3
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 7.1 7.4 7.6 7.8 8.1 8.3 8.6 3.7 3.8 3.9 4.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 5.9 3.9 5.6 3 3 3 3 3 0 0.6 0.2 0.3 0.3 0.4 0.2 0.2 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 3.2 6.4 3.7 6.3 5.7 6.1 3.4 3.4 1.3 1.5 1.3 1.5 0.5 0.6 0.6 0.6 0.9 1.1 1.6 1.5 1.3 0.1 1.8 0.1 0.0
Total Non-Current Assets 43.9 39.4 32.9 20.6 20.0 20.3 19.2 14.3 8.6 9.4 9.1 5.5 2.6 2.5 2.4 2.5 2.7 3.0 3.3 2.5 2.5 1.3 3.1 1.5 0.3
Total Assets 581.1 562.2 534.6 495.0 500.8 377.0 376.3 376.8 349.3 265.5 268.3 188.9 211.2 227.9 236.5 252.8 181.5 178.9 190.4 203.4 194.0 172.0 92.2 56.2 58.3
Current Liabilities
Account Payables 24.1 16.4 40.6 28.1 28.4 27.7 26.8 26.7 19.1 17.8 10.4 8.2 7.6 5.5 5.6 4.1 4.0 2.9 2.0 3.3 5.0 2.2 4.7 1.4 0.5
Short-Term Debt 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 110.3 117.5 62.8 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.1 0.1 0.2 0.3 0.3 0.3 0.1 0
Total Current Liabilities 143.5 135.7 117.0 90.3 86.3 80.6 65.9 51.6 42.5 36.9 23.2 14.8 13.3 15.4 14.3 11.7 12.6 11.5 10.4 10.5 10.1 5.4 6.1 3.1 0.8
Non-Current Liabilities
Long-Term Debt 72.6 83.0 72.3 72.1 72.0 71.8 71.7 71.6 29.9 29.8 29.7 24.6 24.5 19.4 19.4 19.3 19.2 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 (10.6) 0 0 0 0 1.2 1.4 1.6 1.7 1.7 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 103.2 0.1 63.4
Total Non-Current Liabilities 88.7 83.0 82.4 72.1 72.0 71.8 72.9 73.0 31.5 31.6 31.4 26.4 24.6 19.5 19.6 19.6 19.7 0.7 0.9 0.5 0.6 0.6 103.9 0.8 63.5
Total Liabilities 232.2 218.7 199.5 162.4 158.3 152.5 138.8 124.6 74.1 68.5 54.7 41.2 37.8 35.0 33.8 31.3 32.3 12.2 11.3 11.0 10.7 6.0 110.0 3.9 64.3
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (433.6) (426.6) (418.3) (405.7) (385.3) (360.2) (337.1) (313.7) (280.4) (244.7) (202.8) (163.6) (132.2) (108.8) (95.2) (72.7) (66.9) (46.7) (31.8) (16.1) (22.5) (32.8) (21.4) (11.2) (6.0)
Accumulated Other Comprehensive Income (0.3) 0.4 0.3 0.0 0.1 0.2 0.3 (0.2) (0.1) (0.0) (0.0) (0.0) (0.1) (0.1) (0.0) 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 349.0 343.4 335.1 332.6 342.5 224.5 237.5 252.2 275.2 197.0 213.7 147.7 173.4 192.9 202.6 221.5 149.2 166.7 179.1 192.5 183.2 166.0 (17.8) 52.4 (6.0)
Total Liabilities & Equity 581.1 562.2 534.6 495.0 500.8 377.0 376.3 376.8 349.3 265.5 268.3 188.9 211.2 227.9 236.5 252.8 181.5 178.9 190.4 203.4 194.0 172.0 92.2 56.2 58.3
Debt Metrics
Total Debt 88.7 93.6 82.5 72.4 72.4 72.5 72.3 72.2 30.5 30.2 30.1 25.0 25.2 20.2 20.1 20.2 20.4 1.9 2.3 2.1 0.7 0.8 0.8 0.9 0.2
Net Debt (13.5) (90.0) (30.2) (24.2) (103.4) (22.4) (103.9) (108.9) (163.2) (194.7) (196.5) (81.7) (40.8) (51.5) (149.4) (225.2) (154.6) (169.4) (181.5) (174.6) (155.5) (167.3) (85.5) (52.3) (57.8)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2018 Q2 2018 Q1
Operating Activities
Net Income (7.0) (8.4) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.9) (15.7) 6.3 10.4 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
Depreciation & Amortization 0.4 0.4 0.4 0.5 0.5 0.4 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 0 14.3 12.2 8.2 6.9 7.4 7.4 7.5 5.5 5.5 5.2 5.2 3.9 3.7 3.6 3.5 2.7 2.2 2.1 2.8 1.4 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0
Change in Working Capital (29.5) 13.6 19.3 (16.4) (1.9) (5.7) (1.7) 10.3 (8.6) (2.8) 1.4 3.1 (1.4) 0.1 0.0 (2.7) 1.6 0.0 20.2 10.3 (29.2) 0.9 0.1 0.5 (0.1) 0.2 0.0 0.0 0.0
Other Non-Cash Items 11.4 (0.6) (1.1) (1.4) (1.0) (1.2) 8.7 0.9 0.7 (0.5) (0.1) (0.9) (1.2) (1.1) 0.2 0.6 0.6 0.5 0.1 0.0 5.6 0.1 3.2 0.0 0.0 0.4 0.0 0.0 0.0
Operating Cash Flow (24.7) 19.3 18.3 (29.4) (20.7) (22.2) (8.7) (14.4) (37.8) (39.3) (32.4) (23.8) (22.0) (10.9) (18.6) (4.3) (15.3) (12.1) 7.1 20.6 (11.8) (10.0) (6.6) (2.6) (2.0) (0.8) (0.6) (0.3) (0.3)
Investing Activities
Capital Expenditure (5.8) (6.4) (1.9) (1.0) (0.6) (5.1) (0.3) (1.0) (0.2) 0 (4.4) (0.8) (0.3) (0.1) (0.1) (0.1) (0.2) (0.3) (0.1) (0.0) (0.2) 0 (0.1) (0.3) (0.0) (0.0) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (126.8) (36.5) (102.3) (129.7) (125.6) (90.0) (24.1) (50.0) (104.5) 0 0.0 0 (28.7) (92.4) (57.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 74.1 92.1 99.5 79 91.2 35.5 24.5 10.5 2.5 17.9 51.7 64.9 40.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 (5) 3 0 0 0 (4) 0 0 5.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0
Investing Cash Flow (58.6) 49.3 (4.7) (51.7) (34.9) (59.6) 3.1 (40.5) (102.2) 17.9 47.4 64.1 11.3 (87.2) (57.1) (0.1) (0.2) (0.3) (0.1) (0.0) (0.2) 0.1 (0.1) (0.3) (0.0) (0.0) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 (31.9) (0.0) 71.5 0 0 5 0 5 0 0 (0.1) 19.2 0 0 0 0 0 0 0 0 1.0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 31.9 0 (31.9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.1) 0.1 0 0 0 0 0
Financing Cash Flow 1.2 2.3 2.6 2.0 136.6 2.9 0.6 42.3 108.8 19.8 104.9 0.5 5.0 0.3 (0.1) 74.7 19.1 (0.1) 0.1 0.0 0.0 91.8 39.9 0.1 (0.0) 58.4 0.5 0 0
Cash Position
Net Change in Cash (82.0) 70.9 16.1 (79.1) 81.0 (78.8) (4.9) (12.6) (31.2) (1.7) 119.9 40.8 (5.7) (97.8) (75.9) 70.4 3.7 (12.5) 7.1 20.5 (11.9) 81.8 33.2 (2.8) (2.1) 57.6 (0.1) 0.6 0.6
Cash at Beginning 184.2 115.3 99.2 178.3 97.4 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.2 55.9 58.0 0.4 0.4 0.0 0.0
Cash at End 102.2 186.2 115.3 99.2 178.3 97.4 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.2 55.9 58.0 0.4 0.6 0.6
Free Cash Flow (30.5) 13.0 16.3 (30.4) (21.2) (27.3) (8.9) (15.4) (38.0) (39.3) (36.7) (24.6) (22.3) (11.0) (18.7) (4.4) (15.4) (12.4) 7.0 20.5 (12.0) (10.0) (6.7) (2.9) (2.0) (0.8) (0.6) (0.3) (0.3)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2018 Q2 2018 Q1
Income Statement
Revenue 162.1 151.7 118.7 102.7 78.3 66.4 48.1 40.8 27.6 13.1 1.9 0 2.5 10 0 15.3 0.5 0.3 1.2 22.0 33.4 0 0 0 0 0 0 0 0
Gross Profit 152.7 140.7 94.1 96.4 73.1 61.5 44.9 37.8 26.0 11.9 1.5 (0.3) 2.2 9.6 (0.2) 14.8 0.5 0.4 1.2 21.3 32.1 0 0 0 0 0 (0.0) 0 0
Operating Income (6.1) (8.0) (14.5) (22.2) (26.3) (24.4) (25.2) (33.3) (37.7) (44.5) (40.9) (32.8) (25.0) (15.1) (22.9) (5.2) (19.5) (14.4) (15.7) 7.3 10.7 (11.5) (10.1) (3.3) (2.1) (1.1) (0.6) (0.3) (0.3)
Net Income (7.0) (8.4) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.9) (15.7) 6.3 10.3 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
EPS (Diluted) -0.16 -0.20 -0.30 -0.48 -0.64 -0.60 -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.88 -0.53 -0.84 -0.24 -0.98 -0.72 -0.76 0.29 0.47 -0.54 -0.54 -0.30 -0.18 -0.13 -0.06 -0.08 -0.08
Balance Sheet
Cash & Equivalents 102.2 183.6 112.7 96.6 175.8 94.8 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.1 58.0
Total Assets 581.1 562.2 534.6 495.0 500.8 377.0 376.3 376.8 349.3 265.5 268.3 188.9 211.2 227.9 236.5 252.8 181.5 178.9 190.4 203.4 194.0 172.0 92.2 56.2 58.3
Total Debt 88.7 93.6 82.5 72.4 72.4 72.5 72.3 72.2 30.5 30.2 30.1 25.0 25.2 20.2 20.1 20.2 20.4 1.9 2.3 2.1 0.7 0.8 0.8 0.9 0.2
Stockholders' Equity 349.0 343.4 335.1 332.6 342.5 224.5 237.5 252.2 275.2 197.0 213.7 147.7 173.4 192.9 202.6 221.5 149.2 166.7 179.1 192.5 183.2 166.0 (17.8) 52.4 (6.0)
Cash Flow
Operating Cash Flow (24.7) 19.3 18.3 (29.4) (20.7) (22.2) (8.7) (14.4) (37.8) (39.3) (32.4) (23.8) (22.0) (10.9) (18.6) (4.3) (15.3) (12.1) 7.1 20.6 (11.8) (10.0) (6.6) (2.6) (2.0) (0.8) (0.6) (0.3) (0.3)
Capital Expenditure (5.8) (6.4) (1.9) (1.0) (0.6) (5.1) (0.3) (1.0) (0.2) 0 (4.4) (0.8) (0.3) (0.1) (0.1) (0.1) (0.2) (0.3) (0.1) (0.0) (0.2) 0 (0.1) (0.3) (0.0) (0.0) (0.0) (0.0) (0.0)
Free Cash Flow (30.5) 13.0 16.3 (30.4) (21.2) (27.3) (8.9) (15.4) (38.0) (39.3) (36.7) (24.6) (22.3) (11.0) (18.7) (4.4) (15.4) (12.4) 7.0 20.5 (12.0) (10.0) (6.7) (2.9) (2.0) (0.8) (0.6) (0.3) (0.3)